Skip to main navigation
Longboard

Corporate Menu

  • About
    • Overview
    • Management
    • Board of Directors
  • Our Approach
    • Overview
    • GPCR Therapies
    • Pipeline
    • Publications
  • Patients
  • Investors
    • News & Events
      • Events & Presentations
      • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Financials
      • SEC Filings
      • Quarterly Results
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • Longboard Life
  • Contact

Press Releases

May 12, 2022
Longboard Pharmaceuticals to Participate in Upcoming Investor Events
May 5, 2022
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
April 1, 2022
Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting
March 23, 2022
Longboard Pharmaceuticals to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit
March 22, 2022
Longboard Pharmaceuticals to Participate in Maxim Group 2022 Virtual Growth Conference
March 21, 2022
Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer
March 3, 2022
Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results
January 5, 2022
Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
©2022 Longboard Pharmaceuticals  Privacy Policy | Terms of Use
logo

Corporate Menu

  • About
    • Overview
    • Management
    • Board of Directors
  • Our Approach
    • Overview
    • GPCR Therapies
    • Pipeline
    • Publications
  • Patients
  • Investors
    • News & Events
      • Events & Presentations
      • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Financials
      • SEC Filings
      • Quarterly Results
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • Longboard Life
  • Contact